BOSTON - Harvard researchers found a “chemical cocktail” that helped reverse aging in mice within a week by rejuvenating old cells within muscles, tissues, and some organs. Aging and longevity expert David Sinclair, who is a researcher in the Department of Genetics and co-director of the Paul F. Glenn Center for Biology of Aging Research at
JERUSALEM, Israel - An experimental treatment developed at Israel's Hadassah-University Medical Center has a 90% success rate at bringing patients with multiple myeloma into remission. Hadassah-University Medical Center in Jerusalem’s Ein Kerem has announced an “unprecedented achievement” in the treatment of multiple myeloma cancer – the second-most common hematological disease. It accounts for one-tenth of all
BOSTON - Genomic studies of cancer patients have revealed thousands of mutations linked to tumor development. However, for the vast majority of those mutations, researchers are unsure of how they contribute to cancer because there’s no easy way to study them in animal models. In an advance that could help scientists make a dent in
NEW YORK - Imagine using your cellphone to control the activity of your own cells to treat injuries and disease. It sounds like something from the imagination of an overly optimistic science fiction writer. But this may one day be a possibility through the emerging field of quantum biology. Over the past few decades, scientists
NEW YORK - In a significant groundbreaking medical development, researchers have created a tiny device, smaller than a grain of rice, to deliver drugs directly to the pancreatic tumor. In the near future, this implantable nanofluidic device could be a game changer in treating pancreatic cancer. Nanomedicine experts at Houston Methodist Academic Institute developed the
BLOOMFIELD HILLS–Zivo Bioscience Inc., a biotech and agriculture-tech research and development company developing medicines and nutritional products from algae cultures, announced a $1 million unsecured six-month loan from Chairman and CEO John Payne. The loan carries 10% simple interest, may be prepaid without penalty, is extendable for an additional six months and includes warrants to
ANN ARBOR - The University of Michigan Health has officially acquired Lansing-based Sparrow Health System to become a $7 billion health system with more than 200 sites of care, according to an April 3 news release. UM Health and Sparrow said they have received the necessary regulatory approvals to partner after announcing their plans in
LONDON - Artificial intelligence has developed a treatment for an aggressive form of cancer in just 30 days and demonstrated it can predict a patient's survival rate using doctors' notes. The breakthroughs were performed by separate systems, but show how the powerful technology's uses go far beyond the generation of images and text. University of Toronto
LONDON, UK - Scientists have developed a test to identify which blood-cancer patients will benefit the most from a drug that can stop their cancer from returning. The test, which looks for genetic clues in cancer cells, can identify the ten per cent of patients who see little effect from life-saving lenalidomide. This could spare them
DETROIT—The Commission on Accreditation of Healthcare Management Education (CAHME) Board of Directors approved the initial accreditation of University of Detroit Mercy's Master of Science in Health Services Administration (MHSA) program for a three-year term. “This accreditation represents the diligence of our team at University of Detroit Mercy, MHSA, to create a curriculum to prepare graduates
